Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms
出版年份 2021 全文链接
标题
Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms
作者
关键词
Traditional Chinese Medicine (TCM), Viral infections, COVID-19, Jinhua Qinggan granules (JHQG), Lianhua Qingwen capsules (LHQW), Lung Cleansing and Detoxifying Decoction (LCDD), Xuanfeibaidu granules (XFBD), Huashibaidu granules (HSBD), Xuebijing (XBJ), Angiotensin converting enzyme 2 (ACE2), Coronavirus 3-chymotrypsin-like protease (3CL, ), Interleukin-6 (IL-6)
出版物
PHARMACOLOGY & THERAPEUTICS
Volume 225, Issue -, Pages 107843
出版商
Elsevier BV
发表日期
2021-04-01
DOI
10.1016/j.pharmthera.2021.107843
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro
- (2021) Hongbo Liu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs
- (2020) Hui Luo et al. Chinese Journal of Integrative Medicine
- Traditional Chinese Medicine for COVID-19 Treatment
- (2020) Jun-ling Ren et al. PHARMACOLOGICAL RESEARCH
- Is traditional Chinese medicine useful in the treatment of COVID-19?
- (2020) Kai Zhang AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Protection against COVID-19 injury by Qingfei Paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming
- (2020) Jian Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)
- (2020) CHINESE MEDICAL JOURNAL
- IL-6 may be a good biomarker for earlier detection of COVID-19 progression
- (2020) Changsong Wang et al. INTENSIVE CARE MEDICINE
- Shegan-Mahuang Decoction ameliorates asthmatic airway hyperresponsiveness by downregulating Th2/Th17 cells but upregulating CD4+FoxP3+ Tregs
- (2020) Cheng-Chuang Lin et al. JOURNAL OF ETHNOPHARMACOLOGY
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- The potential insights of Traditional Chinese Medicine on treatment of COVID-19
- (2020) Tong Tong et al. Chinese Medicine
- Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection
- (2020) Dan Gao et al. Frontiers in Pharmacology
- Overview of therapeutic drug research for COVID-19 in China
- (2020) Heng Li et al. ACTA PHARMACOLOGICA SINICA
- Treatment strategies of hospitalized patients with coronavirus disease-19
- (2020) Yaxiong Huang et al. Aging-US
- The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic
- (2020) Peng Cao et al. CARBOHYDRATE POLYMERS
- Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19
- (2020) Quyuan Tao et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model
- (2020) Chunguang Yang et al. Evidence-based Complementary and Alternative Medicine
- COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
- (2020) Yang Song et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Homology modeling and in silico design of novel and potential dual-acting inhibitors of human histone deacetylases HDAC5 and HDAC9 isozymes
- (2020) Ammar D. Elmezayen et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience
- (2020) Longrong Wang et al. Journal of Translational Medicine
- Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
- (2020) Ruocong Yang et al. PHARMACOLOGICAL RESEARCH
- Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial
- (2020) Mingzhong Xiao et al. PHARMACOLOGICAL RESEARCH
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Is a “Cytokine Storm” Relevant to COVID-19?
- (2020) Pratik Sinha et al. JAMA Internal Medicine
- The role played by traditional Chinese medicine in preventing and treating COVID-19 in China
- (2020) Qingwei Li et al. Frontiers of Medicine
- Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
- (2020) Vincenzo Montesarchio et al. Journal for ImmunoTherapy of Cancer
- Bioactive natural compounds against human coronaviruses: a review and perspective
- (2020) Yanfang Xian et al. Acta Pharmaceutica Sinica B
- Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial
- (2020) Wu-zhong Xiong et al. Integrative Medicine Research
- Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines
- (2020) Lin Ang et al. Integrative Medicine Research
- Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment
- (2020) Siyi Xin et al. BIOMEDICINE & PHARMACOTHERAPY
- Cytokine Storms in Cancer and COVID-19
- (2020) Casmir Turnquist et al. CANCER CELL
- Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-Analysis
- (2020) Caiyun Hu et al. Evidence-based Complementary and Alternative Medicine
- Evidence-Based Complementary and Alternative Medicine Exploring Active Components and Mechanism of Jinhua Qinggan Granules in Treatment of COVID-19 Based on Virus-Host Interaction
- (2020) Yan Ren et al. Natural Product Communications
- The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2
- (2020) Qinhai Ma et al. PHARMACOLOGICAL RESEARCH
- Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019
- (2020) Xin Li et al. PHARMACOLOGICAL RESEARCH
- Clinical practice guideline on treating influenza in adult patients with Chinese patent medicines
- (2020) Lei Wu et al. PHARMACOLOGICAL RESEARCH
- Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: a non-randomized controlled trial
- (2020) Shi Nannan et al. PHYTOMEDICINE
- Traditional Chinese medicine Lianhua Qingwen treating corona virus disease 2019(COVID-19): Meta-analysis of randomized controlled trials
- (2020) Mengjie Zeng et al. PLoS One
- Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China
- (2020) Xiaoqi Pan et al. VIRUS RESEARCH
- Reflections on treatment of COVID-19 with traditional Chinese medicine
- (2020) Hua Luo et al. Chinese Medicine
- Xuebijing injection in the treatment of COVID-19: a retrospective case-control study
- (2020) Hu Guo et al. Annals of Palliative Medicine
- Protocol for developing clinical practice guidelines on traditional Chinese medicine therapy for influenza
- (2020) Guozhen Zhao et al. Annals of Palliative Medicine
- XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia
- (2019) Yuanlin Song et al. CRITICAL CARE MEDICINE
- Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis
- (2018) Xi Chen et al. JOURNAL OF ETHNOPHARMACOLOGY
- Curative efficacy and safety of traditional Chinese medicine xuebijing injections combined with ulinastatin for treating sepsis in the Chinese population
- (2018) Shi-Hui Xiao et al. MEDICINE
- Efficacy and safety of traditional Chinese medicine for the treatment of influenza A (H1N1): A meta-analysis
- (2016) Jiang-Hong Li et al. Journal of the Chinese Medical Association
- A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components
- (2016) Chun-Hua Wang et al. Molecular BioSystems
- BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine
- (2016) Zhongyang Liu et al. Scientific Reports
- Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice
- (2015) Ying Yang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Efficacy of Xuebijing for coagulopathy in patients with sepsis
- (2015) Si-Yuan Hou et al. SAUDI MEDICAL JOURNAL
- Qualitative and Quantitative Analysis of the Major Constituents in Chinese Medical Preparation Lianhua-Qingwen Capsule by UPLC-DAD-QTOF-MS
- (2015) Weina Jia et al. TheScientificWorldJOURNAL
- Qualitative and Quantitative Analysis of the Major Constituents in Chinese Medical Preparation Lianhua-Qingwen Capsule by UPLC-DAD-QTOF-MS
- (2015) Weina Jia et al. Scientific World Journal
- Treatment Effects of Xuebijing Injection in Severe Septic Patients with Disseminated Intravascular Coagulation
- (2014) Qin Yin et al. Evidence-based Complementary and Alternative Medicine
- TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
- (2014) Jinlong Ru et al. Journal of Cheminformatics
- Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza
- (2013) Chen Wang et al. ANNALS OF INTERNAL MEDICINE
- Current Understanding on Antihepatocarcinoma Effects of Xiao Chai Hu Tang and Its Constituents
- (2013) Ningning Zheng et al. Evidence-based Complementary and Alternative Medicine
- Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus
- (2012) Chung-Fan Hsieh et al. JOURNAL OF ETHNOPHARMACOLOGY
- TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis
- (2012) Ruichao Xue et al. NUCLEIC ACIDS RESEARCH
- Anti-influenza agents from Traditional Chinese Medicine
- (2010) Hu Ge et al. NATURAL PRODUCT REPORTS
- ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
- (2009) Gabriela Bindea et al. BIOINFORMATICS
- The Yellow Emperor’s Classic of Internal Medicine
- (2008) James Curran BMJ-British Medical Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now